In converting sufferers from other opioids to ROXICODONE near observation and adjustment of dosage primarily based upon the affected person’s response to ROXICODONE is crucial. Should the non-opioid routine is continued as a separate solitary entity agent, the starting off dose ROXICODONE must be dependent upon The latest dose of opioid for a